logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Camilla Thellenberg-Karlsson

Umeå University
H指数:21
被引数:2,110

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Morphological heterogeneities in prostate cancer bone metastases are related to molecular subtypes and prognosis

前列腺癌骨转移的形态学异质性与其分子亚型及预后相关

Clinical & Experimental Metastasis
IF3.2
2025-08-210
OAAI
Sofia Halin Bergström; Julius Semenas; Annika Nordstrand; Elin Thysell; Johan Wänman; Sead Crnalic; Anders Widmark; Camilla Thellenberg-Karlsson; Pernilla Andersson; Susanne Gidlund; Marie Lundholm; Karin Welén; Andreas Josefsson; Pernilla Wikström; Anders Bergh
Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial

Crippa, A.; De Laere, B.; Discacciati, A.; Larsson, B.; Persson, M.; Johansson, S.; D’hondt, S.; Hjälm-Eriksson, M.; Pettersson, L.; Enblad, G.; 等. 循环肿瘤DNA分数在转移性去势抵抗性前列腺癌中的预后价值：ProBio平台试验结果. Eur. Urol. Oncol. 2025. [Google Scholar] [CrossRef]

European Urology Oncology
IF9.3
2025-04-210
OAAI
Alessio Crippa; Bram De Laere; Andrea Discacciati; Berit Larsson; Maria Persson; Susanne Johansson; Sanne D’hondt; Marie Hjälm-Eriksson; Linn Pettersson; Gunilla Enblad; Anders Ullén; Nicolaas Lumen; Camilla Thellenberg Karlsson; Johan Sandzén; Elin Jänes; Christophe Ghysel; Martha Olsson; Brieuc Sautois; Peter Schatteman; Wendy De Roock
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial (Aug, 10.1038/s41591-024-03204-2, 2024)
NATURE MEDICINE
IF50
2024-08-280
OAAI
De Laere, Bram; Crippa, Alessio; Discacciati, Andrea; Larsson, Berit; Persson, Maria; Johansson, Susanne; D'hondt, Sanne; Bergstrom, Rebecka; Chellappa, Venkatesh; Mayrhofer, Markus; Banijamali, Mahsan; Kotsalaynen, Anastasijia; Schelstraete, Celine; Vanwelkenhuyzen, Jan Pieter; Hjalm-Eriksson, Marie; Pettersson, Linn; Ullen, Anders; Lumen, Nicolaas; Enblad, Gunilla; Karlsson, Camilla Thellenberg; Janes, Elin; Sandzen, Johan; Schatteman, Peter; Vigmostad, Maria Nyre; Olsson, Martha; Ghysel, Christophe; Sautois, Brieuc; De Roock, Wendy; Van Bruwaene, Siska; Anden, Mats; Verbiene, Ingrida; De Maeseneer, Daan; Everaert, Els; Darras, Jochen; Aksnessether, Bjorg Y.; Luyten, Daisy; Strijbos, Michiel; Mortezavi, Ashkan; Oldenburg, Jan; Ost, Piet; Eklund, Martin; Gronberg, Henrik; Lindberg, Johan
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

雄激素受体途径抑制剂和紫杉烷类药物在转移性前列腺癌中的应用: 一项结果适应性随机平台试验

NATURE MEDICINE
IF50
2024-08-201
OAAI
De Laere, Bram; Crippa, Alessio; Discacciati, Andrea; Larsson, Berit; Persson, Maria; Johansson, Susanne; D'hondt, Sanne; Bergstrom, R.; Chellappa, Venkatesh; Mayrhofer, Markus; Banijamali, Mahsan; Kotsalaynen, Anastasijia; Schelstraete, Celine; Vanwelkenhuyzen, Jan Pieter; Hjaelm-Eriksson, Marie; Pettersson, Linn; Ullen, Anders; Lumen, Nicolaas; Enblad, Gunilla; Thellenberg Karlsson, Camilla; Janes, Elin; Sandzen, Johan; Schatteman, Peter; Nyre Vigmostad, Maria; Olsson, Martha; Ghysel, Christophe; Sautois, Brieuc; De Roock, Wendy; Van Bruwaene, Siska; Anden, Mats; Verbiene, Ingrida; De Maeseneer, Daan; Everaert, Els; Darras, Jochen; Aksnessether, Bjorg Y.; Luyten, Daisy; Strijbos, Michiel; Mortezavi, Ashkan; Oldenburg, Jan; Ost, Piet; Eklund, Martin; Gronberg, Henrik; Lindberg, Johan
Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer-Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial

多西他赛与中危或高危前列腺癌根治性放疗后监测的比较-来自前瞻性，随机，开放标签的III期SPCG-13试验的结果

EUROPEAN UROLOGY
IF25.2
2019-12-0123
OAAI
Kellokumpu-Lehtinen, Pirkko-Liisa; Hjalm-Eriksson, Marie; Thellenberg-Karlsson, Camilla; Astrom, Lennart; Franzen, Lars; Fransson, Ann-Sofie; Leskinen, Markku J.; Zeke, Mihalj; Huttunen, Teppo; Ginman, Claes
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

超分割与常规分割放疗治疗前列腺癌: hypo-rt-pc随机，非劣效性，3期试验的5年结果

LANCET
IF88.5
2019-08-01575
PREAI
Widmark, Anders; Gunnlaugsson, Adalsteinn; Beckman, Lars; Thellenberg-Karlsson, Camilla; Hoyer, Morten; Lagerlund, Magnus; Kindblom, Jon; Ginman, Claes; Johansson, Bengt; Bjornlinger, Kirsten; Seke, Mihajl; Agrup, Mans; Fransson, Per; Tavelin, Bjorn; Norman, David; Zackrisson, Bjorn; Anderson, Harald; Kjellen, Elisabeth; Franzen, Lars; Nilsson, Per
Extreme Hypofractionation versus Conventionally Fractionated Radiotherapy for Intermediate Risk Prostate Cancer: Early Toxicity Results from the Scandinavian Randomized Phase III Trial HYPO-RT-PC
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
IF6.5
2016-12-0129
PREAI
Widmark, A.; Gunnlaugsson, A.; Beckman, L.; Thellenberg-Karlsson, C.; Hoyer, M.; Lagerlund, M.; Fransson, P.; Kindblom, J.; Ginman, C.; Johansson, B.; Seke, M.; Bjornlinger, K.; Kjellen, E.; Franzen, L.; Nilsson, P.

研究方向

暂未获取到该数据
A
Anders Widmark
H 指数:51论文数:270被引数:1.3万
C
Claes Ginman
H 指数:17论文数:41被引数:1,829
L
Lars Franzén
H 指数:33论文数:152被引数:7,899
M
Marie Hjälm-Eriksson
H 指数:11论文数:46被引数:767
L
L. Beckman
H 指数:39论文数:265被引数:1.0万
P
Pernilla Wikström
H 指数:43论文数:175被引数:5,911
A
Anders Ullén
H 指数:23论文数:142被引数:4,037
A
Adalsteinn Gunnlaugsson
H 指数:21论文数:101被引数:2,274
H
Henrik Grönberg
H 指数:99论文数:648被引数:4.7万
M
Marie Lundholm
H 指数:16论文数:52被引数:1,319